Clinical trial
INtravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal functiOn (INCARO) - a Multicentre, Open-label, Randomised Controlled Trial
NCT04196244 is registered in ClinicalTrials.gov with Helsinki University Central Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- INtravenous Contrast Computed Tomography Versus Native Computed Tomography in Patients With Acute Abdomen and Impaired Renal functiOn (INCARO) - a Multicentre, Open-label, Randomised Controlled Trial
- Lead sponsor
- Helsinki University Central Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- September 18, 2020
- Completion date
- September 30, 2033
- Enrollment
- 994 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute abdomen, radiocontrast nephropathy